The Wire The issue of the deaths of 70 children in the Gambia after consuming cough syrup is back in the news again. These deaths were linked to four medicines made by an Indian manufacturer, Maiden Pharmaceuticals. A Gambian presidential task force has now recommended that the government must sue the drug manufacturer, Maiden Pharmaceuticals, and the drug importer, Atlantic Pharmaceuticals.  It also wants the Government of India to be sued. This...

Livemint Recent deaths in Gambia, Uzbekistan and the US, allegedly caused by toxic drugs made in India, has the Centre reportedly planning to centralize drug regulation. How effective will this measure be? The Central Drugs Standard Control Organization (CDSCO) is the apex regulatory body. Each state has its own regulator. The state regulators look after licencing and audit manufacturing facilities while CDSCO is responsible for approving new drugs, imports of devices, clinical...

-PTI/ NDTV.com The DCGI said Gambia has informed, according to media, that there has been no direct causal relation established yet between the cough syrup consumption and the deaths. New Delhi: The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe, India's drug regulator has told the global health body. In...

-The Hindu Business Line Experts say authorities will need to probe and take quick action, in the interest of keeping the faith in medicine exports from India The death of 66 children in Gambia, potentially-linked to four cough and cold syrups made in India by Maiden Pharmaceuticals, has brought up the quality question, again. How did an allegedly contaminated product slip through the regulatory cracks, casting a long shadow on the Indian...

-IndiaToday.in The Central Drugs Standard Control Organisation (CDSCO) has not yet barred the company from operations in India even as many of its medical products made for Indian use have also been found to be of substandard quality, often flagged by authorities. Ever since Maiden Pharmaceuticals has come under the scanner of the World Health Organisation (WHO) after being flagged for the four cough syrups manufactured in India and exported to Gambia...